News Wire
MarketsMizuho Raises Elevance Health (ELV) PT to $413 Citing Peaking Healthcare Utilization Growth
Mizuho has increased its price target for Elevance Health (ELV) to $413, up from $400, while maintaining a 'Buy' rating. The upgrade is driven by Mizuho's belief that healthcare utilization growth, a key metric for health insurers, is stabilizing or peaking, which suggests a more predictable and potentially profitable environment for companies like Elevance Health.
Related Articles
Netanyahu Says Ceasefire Doesn’t Include Lebanon (Video)
bearish
Bloomberg
38 minutes ago
Stocks Set to Surge as Two-Week Ceasefire Agreed
bullish
Bloomberg
about 1 hour ago
Islamabad Talks Collide With Friday’s $2 Billion Options Expiry as Ceasefire Crushes Volatility
neutral
Yahoo Finance
about 1 hour ago
Duke Energy (DUK) Target Raised as Utilities Outlook Improves
bullish
Yahoo Finance
about 2 hours ago
You May Also Like
Netanyahu Says Ceasefire Doesn’t Include Lebanon (Video)
Bloomberg•38 minutes ago
Stocks Set to Surge as Two-Week Ceasefire Agreed
Bloomberg•about 1 hour ago
Islamabad Talks Collide With Friday’s $2 Billion Options Expiry as Ceasefire Crushes Volatility
Yahoo Finance•about 1 hour ago
Duke Energy (DUK) Target Raised as Utilities Outlook Improves
Yahoo Finance•about 2 hours ago
Emerging-Market Assets Rally as Iran Ceasefire Spurs Risk Demand
Bloomberg•about 3 hours ago
China Vanke Seeks to Delay Another Bond Payment to Avoid Default
Bloomberg•about 3 hours ago